Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer

Gynecologic Oncology

Volumn 101, Issue 1, 2006, Pages 12-17

  Hylander, Bonnie ^a   Repasky, Elizabeth ^a   Shrikant, Protul ^a   Intengan, Marilyn ^a   Beck, Amy ^a   Driscoll, Deborah ^a   Singhal, Pankaj ^a   Lele, Shashikant ^a   Odunsi, Kunle ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Immunogenicity; Immunotherapy; Ovarian cancer; Prognosis; WT1

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE EXPRESSION; GRANULOSA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; KIDNEY; LOG RANK TEST; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROBABILITY; SERTOLI CELL; SPLEEN; STAINING; STATISTICAL SIGNIFICANCE; SURVIVAL; TESTIS; TISSUE MICROARRAY; WILMS TUMOR GENE 1;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION; GENES, WILMS TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; TREATMENT OUTCOME; WT1 PROTEINS;

EID: 33644520931     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.09.052     Document Type: Article

References (19)

1. R.T. Greenlee, M.B. Hill-Harmon, T. Murray, and M. Thun Cancer statistics, 2001 CA Cancer J. Clin. 51 1 2001 15 36
2. W.P. McGuire, W.J. Hoskins, and M.F. Brady Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group) Semin. Oncol. 23 5 Suppl 12 1996 40 47
3. K.M. Call, T. Glaser, and C.Y. Ito Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus Cell 60 3 1990 509 520
4. H. Sugiyama Wilms' tumor gene WT1: its oncogenic function and clinical application Int. J. Hematol. 73 2 2001 177 187
5. K. Pritchard-Jones, S. Fleming, and D. Davidson The candidate Wilms' tumour gene is involved in genitourinary development Nature 346 6280 1990 194 197
6. A.K. Charles, S. Mall, J. Watson, and P.J. Berry Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study Mol. Pathol. 50 3 1997 138 144
7. W. Bruening, P. Gros, and T. Sato Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors Cancer Invest. 11 4 1993 393 399
8. M. Shimizu, T. Toki, Y. Takagi, I. Konishi, and S. Fujii Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors Int. J. Gynecol. Pathol. 19 2 2000 158 163
9. H. Hwang, L. Quenneville, H. Yaziji, and A.M. Gown Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin Appl. Immunohistochem. Mol. Morphol. 12 2 2004 122 126
10. H. Ohminami, M. Yasukawa, and S. Fujita HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide Blood 95 1 2000 286 293
11. M. Makita, A. Hiraki, and T. Azuma Antilung cancer effect of WT1-specific cytotoxic T lymphocytes Clin. Cancer Res. 8 8 2002 2626 2631
12. S.F. Serov, R.E. Scully, and L.H. Sobin Histological typing of ovarian tumors International classification of tumors vol. 9 1973 World Health Organization
13. SPSS. SPSS advanced statistics. 7.5 edition. Chicago: SPSS; 1997.
14. E.L. Kaplan, and P. Meir Nonparametric estimation from incomplete observations J. Am. Stat. Assoc. 53 1958 457 486
15. D.R. Cox Regression models and life-tables J. R. Stat. Soc. 34 1972 187 220
16. L. Zhang, J.R. Conejo-Garcia, and D. Katsaros Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N. Engl. J. Med. 348 3 2003 203 213
17. N.S. Goldstein, D. Bassi, and A. Uzieblo WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms Am. J. Clin. Pathol. 116 2 2001 246 252
18. Y. Oka, A. Tsuboi, O.A. Elisseeva, K. Udaka, and H. Sugiyama WT1 as a novel target antigen for cancer immunotherapy Curr. Cancer Drug Targets 2 1 2002 45 54
19. Y. Oka, A. Tsuboi, and T. Taguchi Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression Proc. Natl. Acad. Sci. U. S. A. 101 38 2004 13885 13890